| Field | Specification |
|---|---|
| Target | |
| Alternative names | Matrix metalloproteinase-9;MMP-9;3.4.24.35;92 kDa gelatinase;92 kDa type IV collagenase;Gelatinase B;GELB;67 kDa matrix metalloproteinase-9;82 kDa matrix metalloproteinase-9;MMP9;CLG4B; |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | A synthetic peptide corresponding to a sequence at the C-terminus of human MMP-9, different from the related mouse sequence by fourteen amino acids, and from the related rat sequence by sixteen amino acids. |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Lyophilized |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
This rabbit polyclonal antibody targets matrix metalloproteinase-9 (gene MMP9) in human samples and is validated for ELISA, IHC and Western blot. The predicted molecular weight is 78.5 kDa, and the supplier reports an observed band at about 79 kDa.
MMP-9 (gelatinase B) is a secreted matrix metalloproteinase that degrades type IV and V collagens, gelatin and other matrix proteins. It supports leukocyte migration, tissue remodeling and osteoclast bone resorption, and it is widely measured in studies of inflammation, vascular disease, and tumor invasion.
| Target | Matrix metalloproteinase-9 (gene MMP9; UniProt P14780, human) |
|---|---|
| Host / Clonality / Isotype | Rabbit / Polyclonal / Rabbit IgG |
| Reactivity | Human |
| Form | Lyophilized |
| Formulation | Per vial: 0.9 mg NaCl; 0.2 mg Na2HPO4; 0.05 mg NaN3; plus stabilizers |
| Calculated MW | 78.5 kDa |
| Observed MW | 79 kDa |
| Storage | As supplied: −20 °C for up to 12 months from receipt. After reconstitution: 4 °C for up to 1 month, or aliquot and keep at −20 °C for up to 6 months. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 0.1–0.5 µg/mL (Human) |
|---|---|
| IHC (paraffin sections) | 2–5 µg/mL (Human) |
| ELISA | 0.1–0.5 µg/mL |
Samples with a confirmed band (WB): human A549 cells.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 5–20% gradient SDS-PAGE under reducing conditions, 30 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 0.5 µg/mL overnight at 4 °C, HRP-conjugated secondary antibody at 1:5000, ECL detection.
Samples with confirmed staining (IHC): human liver cancer tissue, human lymphadenoma tissue, human lymph nodes of gastric adenocarcinoma rectal cancer tissue, human colonic adenocarcinoma tissue.
Recommended antigen retrieval: heat-mediated, in TE buffer (pH 9.0); citrate buffer (pH 6.0) can be used instead.
Conditions in the example images (IHC): heat-mediated antigen retrieval in EDTA buffer (pH 8.0).
Immunogen
Synthetic peptide from the C-terminal region of human MMP-9. It differs from the mouse sequence at fourteen residues and from the rat sequence at sixteen residues.
Reactivity Notes
The supplier lists reactivity with human. Tissue expression noted by UniProt (human): Detected in neutrophils (at protein level). The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Zhao Yingying et al. (2025) A glucose-enriched lung pre-metastatic niche triggered by matrix stiffness-tuned exosomal miRNAs in hepatocellular carcinoma. Nature Communications. 10.1038/s41467-025-56878-8
Zheng Zi-Qi et al. (2020) Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance. Cancer Research. 10.1158/0008-5472.CAN-19-3626
Yaxiu Guo et al. (2017) Cytotoxic necrotizing factor 1 promotes prostate cancer progression through activating the Cdc42–PAK1 axis. Journal of Pathology. 10.1002/path.4940
Zhang Peijian et al. (2022) Pro-inflammatory mediators released by activated monocytes promote aortic valve fibrocalcific activity. Molecular Medicine. 10.1186/s10020-022-00433-4
Hao Qin et al. (2017) PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling. Cancer Letters. 10.1016/j.canlet.2017.08.019
Li Peifei et al. (2017) Circular RNA 0000096 affects cell growth and migration in gastric cancer. British Journal of Cancer. 10.1038/bjc.2016.451
Liu Ying et al. (2016) TGF-β1 promotes scar fibroblasts proliferation and transdifferentiation via up-regulating MicroRNA-21. Scientific Reports. 10.1038/srep32231
Yan Zhang et al. (2017) Tetrahydrocurcumin induces mesenchymal-epithelial transition and suppresses angiogenesis by targeting HIF-1α and autophagy in human osteosarcoma. Oncotarget. 10.18632/oncotarget.19845
Zeqian Yu et al. (2017) Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation. Oncotarget. 10.18632/oncotarget.18831
Qiong Xu et al. (2017) Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling. Oncotarget. 10.18632/oncotarget.15216
